TrialCancer research and treatment2022

Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).

Grace S Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.